Hypertension in Breast Cancer Patients Receiving Bevacizumab
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Rapamycin Plus Bevacizumab in Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
- Status
- COMPLETED
- Phase
- N/A
Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Long Acting Gas in Diabetic Vitrectomy
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)
- Status
- TERMINATED
- Phase
- PHASE2
Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)
- Status
- UNKNOWN
- Phase
- NA
A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2